BioSpace News Archive

Drug Development

Positive Data Back Blueprint’s Bid for sNDA in Systemic Mastocytosis

Blueprint Medicines’ Ayvakit is headed to the FDA for a new indication after the drug hit the mark in Part 2 of the PIONEER trial for non-advanced systemic mastocytosis.

August 17, 2022
·
2 min read
·
Mark Terry
Policy

In Historic Ruling, FDA Allows Sale of Over-the-Counter Hearing Aids

The FDA expects to foster innovation and competition among manufacturers, which would lower the prices of hearing aids without compromising their quality.

August 17, 2022
·
2 min read
·
Tristan Manalac
Women’s Health Diagnostics Market: Increase in Awareness among People about the Availability of Treatments for Sexually Transmitted Diseases to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – Women’s health diagnostics are used to analyze and detect health issues in women such as breast cancer, cervical cancer, fertility & pregnancy testing, and infectious disease testing.

August 17, 2022
·
13 min read
Drug Development

Global Roundup: Ryvu Secures $22.4M Investment, Tessa and Enlivex Start New Trials

Ryvu and Opthea have new funding to work with, Tessa Therapeutics and Enlivex kick off new trials and Revive Therapeutics amends the Phase III protocol for its COVID-19 hopeful.

August 17, 2022
·
4 min read
·
Alex Keown
Phototherapy Market Will Reach USD 784.0 Million By 2028

According to the current analysis of Reports and Data, the global Phototherapy market was valued at USD 554.6 Million in 2020 and is expected to reach USD 784.0 Million by year 2028, at a CAGR of 4.6%.

August 17, 2022
·
7 min read
bluebird bio Scores First U.S. Approval for Lentiviral Vector Gene Therapy

The approval, which was made under Priority Review, is a watershed moment in gene therapy as it marks the first FDA green light for a lentiviral vector.

August 17, 2022
·
4 min read
·
Alex Keown
Drug Development

Newly Discovered Peptide could Prevent Seizures in Epilepsy, Alzheimer’s

Researchers recently developed a peptide called A1R-CT that could ultimately have therapeutic applications in both epilepsy and Alzheimer’s disease.

August 17, 2022
·
2 min read
·
Katherine Davis
Anxiety Disorder and Depression Treatment Market Is Expected To Reach USD 19.53 Billion By 2028

The Global Anxiety Disorder and Depression Treatment Market size is forecast to reach USD 19.53 Billion by 2028, registering a CAGR of 2.4% over the forecast period, according to a new report by Reports and Data.

August 17, 2022
·
6 min read
Drug Development

Paxlovid Rebound: RWE Analysis and Alternative Therapies in Development

Researchers at Case Western University looked at the real-world experiences of 13,644 patients who were treated with Paxlovid or Lagevrio (molnupiravir) during the first half of 2022.

August 17, 2022
·
5 min read
·
Gail Dutton
Metastatic urothelial carcinoma Market Size Worth USD 2.71 Billion By 2027

According to the current analysis of Emergen Research, the Metastatic urothelial carcinoma market was valued at USD 725.9 million in 2019 and is expected to reach USD 2.71 billion by the year 2027, at a CAGR of 17.9%.

August 17, 2022
·
6 min read